An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
暂无分享,去创建一个
Fritz L. Laux | T. Schelling | Daron Acemoglu | J. Newhouse | F. Chaloupka | W. Max | K. Warner | J. Gruber | J. Sindelar | F. Laux
暂无分享,去创建一个
Fritz L. Laux | T. Schelling | Daron Acemoglu | J. Newhouse | F. Chaloupka | W. Max | K. Warner | J. Gruber | J. Sindelar | F. Laux